SHARx: TrumpRx platform exposes issues in drug pricing and access
SHARx argues that without tackling rebate-driven economics and PBM decision-making power, efforts to lower drug prices may have limited impact on patients.
SHARx argues that without tackling rebate-driven economics and PBM decision-making power, efforts to lower drug prices may have limited impact on patients.
Candy is the leading shopping category for Easter this year, with 92% of consumers planning to purchase sweets.
Two-thirds of North American adults (66%) say they deserve an Easter basket just as much as children do.
Numerator reports consumers are adjusting to new nutrition guidance, but increased grocery costs and ingrained habits restrict change.
A typical Easter candy budget now purchases approximately 40% less product than it did six years ago.
“Consumer spending was a steady and reliable engine of growth in 2025,” NRF President and CEO Matthew Shay said.
Shoppers say updated dietary guidance could influence at-home eating habits.
AI-guided analysis helps brands and retailers turn data into decision-ready insights.
Study reveals significant increase in CGM usage, particularly among older adults with chronic health conditions.
A new scientific report highlights how dietary strategies, protein intake and bioactive nutrients can support resilience, reduce chronic disease risk and extend healthspan.
Shoppers increasingly prefer targeted health products over traditional daily multivitamins, focusing on cognitive, gut, cardiovascular, and joint support.
New report tracks how gender-responsive practices that improve the health of women are embedded across pharma, MedTech, consumer health, payor, provider, and investor value chains.
The expansion reflects rising consumer awareness of nutrition, immunity, wellness, and an aging population seeking products for chronic conditions and healthy aging.
NIQ and Kearney analysis finds challenger brands gaining share as AI reshapes innovation and product discovery
U.S. retailers face growing demand for transparency in strain labeling and CFU counts among informed supplement consumers.
As AI-powered diagnostics, AR try-ons, and science-backed formulas continue to grow, U.S. retail will be a key driver in shaping global beauty innovation through 2032.